These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33894736)

  • 1. A narrative review of COVID-19: magnesium isoglycyrrhizinate as a potential adjuvant treatment.
    Tang C; Ding H; Sun Y; Han Z; Kong L
    Ann Palliat Med; 2021 Apr; 10(4):4777-4798. PubMed ID: 33894736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium isoglycyrrhizinate ameliorates lipopolysaccharide-induced liver injury by upregulating autophagy and inhibiting inflammation via IL-22 expression.
    Zhou X; Li X; Yi K; Liang C; Geng S; Zhu J; Xie C; Zhong C
    Bioorg Chem; 2022 Nov; 128():106034. PubMed ID: 35908353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium isoglycyrrhizinate attenuates D-galactosamine/lipopolysaccharides induced acute liver injury of rat via regulation of the p38-MAPK and NF-κB signaling pathways.
    Wang W; Li X; Xu J
    Immunopharmacol Immunotoxicol; 2018 Jun; 40(3):262-267. PubMed ID: 29486613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury.
    Zou X; Wang Y; Peng C; Wang B; Niu Z; Li Z; Niu J
    Int J Mol Med; 2018 Oct; 42(4):2020-2030. PubMed ID: 30066834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium Isoglycyrrhizinate Reduces Hepatic Lipotoxicity through Regulating Metabolic Abnormalities.
    Lu L; Hao K; Hong Y; Liu J; Zhu J; Jiang W; Zhu Z; Wang G; Peng Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway.
    Xie C; Li X; Wu J; Liang Z; Deng F; Xie W; Zhu M; Zhu J; Zhu W; Geng S; Zhong C
    Inflammation; 2015 Aug; 38(4):1639-48. PubMed ID: 25691139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of Ethanol-Induced Hepatitis by Magnesium Isoglycyrrhizinate through Inhibition of Neutrophil Cell Infiltration and Oxidative Damage.
    Wang Y; Zhang Z; Wang X; Qi D; Qu A; Wang G
    Mediators Inflamm; 2017; 2017():3526903. PubMed ID: 28951632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified rehabilitation exercises for mild cases of COVID-19.
    Zha L; Xu X; Wang D; Qiao G; Zhuang W; Huang S
    Ann Palliat Med; 2020 Sep; 9(5):3100-3106. PubMed ID: 32787373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
    Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
    Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of binding interaction between magnesium isoglycyrrhizinate and human serum albumin.
    Wang C; Shi D; Zhang F; Yu X; Lin G; Zhou Z
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jun; 234():118245. PubMed ID: 32179463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.
    Xu X; Yu C; Qu J; Zhang L; Jiang S; Huang D; Chen B; Zhang Z; Guan W; Ling Z; Jiang R; Hu T; Ding Y; Lin L; Gan Q; Luo L; Tang X; Liu J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1275-1280. PubMed ID: 32107577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.
    Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
    IUBMB Life; 2017 Jul; 69(7):540-552. PubMed ID: 28500689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
    Zhang T; Sun LX; Feng RE
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium isoglycyrrhizinate ameliorates radiation-induced pulmonary fibrosis by inhibiting fibroblast differentiation via the p38MAPK/Akt/Nox4 pathway.
    Yang Q; Zhang P; Liu T; Zhang X; Pan X; Cen Y; Liu Y; Zhang H; Chen X
    Biomed Pharmacother; 2019 Jul; 115():108955. PubMed ID: 31075733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function.
    Tang GH; Yang HY; Zhang JC; Ren JJ; Sang XT; Lu X; Zhong SX; Mao YL
    World J Gastroenterol; 2015 Nov; 21(43):12370-80. PubMed ID: 26604644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice.
    Ma D; Zhang J; Zhang Y; Zhang X; Han X; Song T; Zhang Y; Chu L
    Int Immunopharmacol; 2018 Feb; 55():237-244. PubMed ID: 29274625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
    Sui M; Jiang X; Chen J; Yang H; Zhu Y
    Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy.
    Fan Z; Li Y; Chen S; Xu L; Tian Y; Cao Y; Pan Z; Zhang X; Chen Y; Ren F
    Front Pharmacol; 2021; 12():794319. PubMed ID: 35058778
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.
    Li TS; Chen L; Wang SC; Yang YZ; Xu HJ; Gu HM; Zhao XJ; Dong P; Pan Y; Shang ZQ; Zhang XQ; Kong LD
    Biochem Pharmacol; 2019 Aug; 166():139-152. PubMed ID: 31085161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.